PharmaEssentia Corporation (LUX:261280523)

Luxembourg flag Luxembourg · Delayed Price · Currency is EUR · Price in USD
18.80
-0.20 (-1.05%)
At close: Jun 27, 2025
8.67%
Market Cap 5.51B
Revenue (ttm) 315.28M
Net Income (ttm) 108.40M
Shares Out n/a
EPS (ttm) 0.32
PE Ratio 50.84
Forward PE 28.00
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open n/a
Previous Close 19.00
Day's Range n/a
52-Week Range 13.60 - 23.60
Beta n/a
RSI 62.51
Earnings Date Aug 12, 2025

About PharmaEssentia

PharmaEssentia Corporation, a biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally. Its products include Ropeginterferon alfa-2b that is used for the treatment of chronic myelogenous leukemia, T-Cell leukemia, early myelofibrosis, polycythemia vera, and essential thrombocythemia. The company also develops TCRT, anti PD-1, PEG-cytokine X,Y, and novel checkpoint abs for the treatment of solid tumors; P1101 + anti PD-1 for the treatment of hepatocellular carcinoma; and PEG-GCSF for the treatment of neutro... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1990
Employees 131
Stock Exchange Luxembourg Stock Exchange
Ticker Symbol 261280523
Full Company Profile

Financial Performance

Financial numbers in TWD Financial Statements

News

There is no news available yet.